Jim Kever - Luminex Independent Director

Director

Mr. Jim D. Kever is an Independent Director of Luminex Corporationration, since December 1996. He is a founding member of Voyent Partners, L.L.C., a private investment company. Mr. Kever served as cochief executive officer of the transaction services division of WebMD Corporationrationration, a provider of healthcare transaction, information and technology services, from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles Transnational Corporationrationration, a contract research company providing a wide range of clinical research services for biotech and pharmaceutical clients. From August 1995 through March 1999, Mr. Kever was the president and cochief executive officer of Envoy Corporation, a provider of electronic transaction processing services for the healthcare industry. Mr. Kever serves on the boards of directors of 3D Systems Corporation, a provider of 3D printing, rapid prototyping and manufacturing solutions, and has served as a director of Tyson Foods, Inc., a food processing company, ACI Worldwide, Inc., a payment systems company, and Emdeon Corporationrationration, a provider of revenue and payment cycle solutions since 1996.
Age 63
Tenure 28 years
Phone512 219-8020
Webwww.luminexcorp.com
Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.

Luminex Management Efficiency

The company has return on total asset (ROA) of 5.06 % which means that it generated a profit of $5.06 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 4.97 %, meaning that it created $4.97 on every $100 dollars invested by stockholders. Luminex's management efficiency ratios could be used to measure how well Luminex manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 274.91 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Luminex has a current ratio of 8.2, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Luminex until it has trouble settling it off, either with new capital or with free cash flow. So, Luminex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Luminex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Luminex to invest in growth at high rates of return. When we think about Luminex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Reuben LeibowitzSimon Property Group
73
Larry GlasscockSimon Property Group
72
Virginia AddicottCDW Corp
54
Thomas JohnsonUniversal
70
James BellCDW Corp
69
Allan HubbardSimon Property Group
73
Gerhard PleuhsKeurig Dr Pepper
63
Main KohdaJapan Tobacco ADR
65
Robert KotickThe Coca Cola
57
Samuel NunnThe Coca Cola
78
Theodore BroomeUniversal
70
Helene GayleThe Coca Cola
65
Robert SleddUniversal
67
Paul MichaelsKeurig Dr Pepper
68
Diana CantorUniversal
62
Barry DillerThe Coca Cola
79
Muneaki FujimotoJapan Tobacco ADR
N/A
Dirk PutKeurig Dr Pepper
59
Ana OSheaThe Coca Cola
61
Marc BollandThe Coca Cola
61
Caroline TsayThe Coca Cola
39
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Luminex Corporation was founded in 1995 and is based in Austin, Texas. Luminex Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1325 people. Luminex (LMNX) is traded on NASDAQ Exchange in USA and employs 1,325 people.

Management Performance

Luminex Leadership Team

Elected by the shareholders, the Luminex's board of directors comprises two types of representatives: Luminex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Luminex. The board's role is to monitor Luminex's management team and ensure that shareholders' interests are well served. Luminex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Luminex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Nachum Shamir, CEO and Pres
Jim Kever, Independent Director
Thomas Erickson, Independent Director
Nancy Fairchild, Senior Vice President-Human resources
Jay Johnston, Independent Director
Todd Bennett, Senior Vice President - Global Sales and Customer Operations
Tadd Lazarus, Senior Vice President
Walter Loewenbaum, Independent Chairman of the Board
George Loewenbaum, Independent Chairman of the Board
Edward Ogunro, Independent Director
Randall Myers, Senior Vice President - Global Manufacturing and Quality
Kevin McNamara, Independent Director
Robert Cresci, Independent Director
Kenneth Samet, Director
Fred Goad, Independent Director
Richard Rew, Senior Vice President General Counsel, Secretary
Russell Bradley, Chief Marketing and Sales Officer and Sr. VP - Corporate Devel.
Stephen Eck, Independent Director
Harriss Currie, CFO, Principal Accounting Officer, Sr. VP of Fin. and Treasurer
Jimmy Kever, Independent Director
Matthew Scalo, Senior Director, Investor Relations

Luminex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Luminex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Luminex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Luminex's short interest history, or implied volatility extrapolated from Luminex options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Luminex Stock

If you are still planning to invest in Luminex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Luminex's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum